Intermediate-term results after partial left ventriculectomy for end-stage dilated cardiomyopathy: Is there a survival benefit?

Journal of Cardiac Surgery

Volumn 16, Issue 2, 2001, Pages 153-158

  Etoch, Steven W ^a,b   Cerito, Patricia ^a   Henahan, Betty J ^a   Gray Jr , Laman A ^a   Dowling, Robert D ^a  

^a UNIVERSITY OF LOUISVILLE   (United States)

^b University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; FEMALE; FOLLOW UP; HEART DILATATION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE VOLUME; HEART SURGERY; HUMAN; MALE; PARTIAL LEFT VENTRICULECTOMY; POSTOPERATIVE COMPLICATION; SURGICAL MORTALITY; SURVIVAL RATE; SYMPTOMATOLOGY; TREATMENT OUTCOME;

EID: 0035192421     PISSN: 08860440     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8191.2001.tb00501.x     Document Type: Article

References (13)

1. Partial left ventriculectomy with mitral valve preservation in the treatment of patients with dilated cardiomyopathy
2. Results of partial left ventriculectomy in patients with end-stage idiopathic dilated cardiomyopathy
3. The registry of the international society for heart and lung transplantation: Fifteenth Official Report - 1998
4. Partial left ventriculectomy to improve left ventricular function in end-stage heart disease
5. Partial left ventriculectomy to treat end-stage heart disease
6. Partial left ventriculectomy and mitral valve repair for end-stage congestive heart failure
7. Effects of partial left ventriculectomy on left ventricular performance in patients with nonischemic dilated cardiomyopathy
8. Partial left ventricutectomy for idiopathic dilated cardiomyopathy: Early results and six-month follow-up
9. Natural history of idiopathic dilated cardiomyopathy: Effect of referral bias and secular trend
10. Prediction of outcome in dilated cardiomyopathy
11. Predicting death from progressive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy
12. Target heart failure populations for newer therapies
13. Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction